RNA-Binding Motif Protein 38 as a Potential Biomarker and Therapeutic Target in Cancer
Xiaomin She, Yan Lin, Rong Liang, Ziyu Liu, Xing Gao, Jiazhou Ye Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of ChinaCorrespondence: Jiazhou Ye Tel +86 7715301253Email nnsz20013@163.comAbstract: RNA-binding proteins (RBPs) act as a key factor in...
Main Authors: | She X, Lin Y, Liang R, Liu Z, Gao X, Ye J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/rna-binding-motif-protein-38-as-a-potential-biomarker-and-therapeutic--peer-reviewed-article-OTT |
Similar Items
-
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
by: Jiazhou Ye, et al.
Published: (2018-09-01) -
PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer
by: Xu-Jie Zhou, et al.
Published: (2017-10-01) -
RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways
by: Ram KC eVenigalla, et al.
Published: (2012-12-01) -
Rbm38 Reduces the Transcription Elongation Defect of the <i>SMEK2</i> Gene Caused by Splicing Deficiency
by: Shintaro Muraoka, et al.
Published: (2020-11-01) -
The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
by: Xiao-Xia Li, et al.
Published: (2017-04-01)